Immunome (IMNM) Payables: 2023-2025
Historic Payables for Immunome (IMNM) over the last 3 years, with Sep 2025 value amounting to $6.1 million.
- Immunome's Payables rose 74.73% to $6.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $34.1 million, marking a year-over-year increase of 62.06%. This contributed to the annual value of $14.2 million for FY2024, which is 328.54% up from last year.
- Immunome's Payables amounted to $6.1 million in Q3 2025, which was up 31.91% from $4.7 million recorded in Q2 2025.
- Over the past 5 years, Immunome's Payables peaked at $14.2 million during Q4 2024, and registered a low of $2.8 million during Q3 2023.
- Moreover, its 3-year median value for Payables was $4.7 million (2025), whereas its average is $5.9 million.
- Per our database at Business Quant, Immunome's Payables soared by 328.54% in 2024 and then slumped by 33.87% in 2025.
- Quarterly analysis of 3 years shows Immunome's Payables stood at $3.3 million in 2023, then spiked by 328.54% to $14.2 million in 2024, then spiked by 74.73% to $6.1 million in 2025.
- Its Payables was $6.1 million in Q3 2025, compared to $4.7 million in Q2 2025 and $9.1 million in Q1 2025.